Lv2
114 积分 2024-07-08 加入
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?
2小时前
待确认
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
6天前
已完结
A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis
6天前
已完结
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
12天前
已完结
PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension
1个月前
已完结
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
2个月前
已完结
[Protective effect of anti-idiopathic pulmonary fibrosis drug Pirfenidone and Sufenidone (SC1011) on pulmonary injury induced by tuberculosis in a mouse tuberculosis model]
2个月前
已完结
A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium‐Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic Diseases
2个月前
已完结
Pulmonary fibrosis: from pathogenesis to clinical decision-making
3个月前
已完结
Transglutaminases in fibrosis—overview and recent advances
3个月前
已完结
皖公网安备34019202002308
